Cancer Cell
Volume 17, Issue 5, 18 May 2010, Pages 497-509
Journal home page for Cancer Cell

Article
PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and Gliomas

https://doi.org/10.1016/j.ccr.2010.03.020Get rights and content
Under an Elsevier user license
open archive

Summary

A hallmark feature of glioblastoma is its strong self-renewal potential and immature differentiation state, which contributes to its plasticity and therapeutic resistance. Here, integrated genomic and biological analyses identified PLAGL2 as a potent protooncogene targeted for amplification/gain in malignant gliomas. Enhanced PLAGL2 expression strongly suppresses neural stem cell (NSC) and glioma-initiating cell differentiation while promoting their self-renewal capacity upon differentiation induction. Transcriptome analysis revealed that these differentiation-suppressive activities are attributable in part to PLAGL2 modulation of Wnt/β-catenin signaling. Inhibition of Wnt signaling partially restores PLAGL2-expressing NSC differentiation capacity. The identification of PLAGL2 as a glioma oncogene highlights the importance of a growing class of cancer genes functioning to impart stem cell-like characteristics in malignant cells.

Highlights

PLAGL2 is targeted for amplification/gain in GBM as well as in colorectal cancers ► Enforced PLAGL2 expression suppresses NSC/progenitor cell differentiation ► PLAGL2 functions to sustain glioma initiation cell “stemness” upon differentiation ► PLAGL2 activates Wnt/β-catenin pathway in NSC/progenitor cells

CELLCYCLE
STEMCELL
SIGNALING

Cited by (0)

10

These authors contributed equally to this work